688575.SS Overview

Company Profile

Shenzhen YHLO Biotech Co., Ltd. researches, develops, produces, sells, and services in vitro diagnostic instruments and reagents in China and internationally. It offers chemiluminescence immunoassay analyzer, diabetes instruments and related reagents, automated biochemical analyzer, laboratory automation, tenfly phoenix blot analyzer, VISION Pro ESR analyzer, and VISION ESR analyzer. The company was founded in 2008 and is headquartered in Shenzhen, China.

Related stocks

2190.HK

2190.HK • China

20.5 HKD

861.68M USD 1Y -17.1%

2697.HK

2697.HK • China

183 HKD

1.2B USD

1302.HK

1302.HK • China

1.35 HKD

757.09M USD 1Y -36.9%

300143.SZ

300143.SZ • China

7.95 CNY

1.16B USD 1Y -9%

600055.SS

600055.SS • China

BEIJING WANDONG MEDICAL TECHNOL

10.48 CNY

1.1B USD 1Y -41.3%

301367.SZ

301367.SZ • China

46.71 CNY

875.66M USD 1Y -20.4%

688626.SS

688626.SS • China

XIANGYU MEDICAL CO LTD

40.49 CNY

969.39M USD 1Y -22.7%

600587.SS

600587.SS • China

SHINVA MEDICAL INSTRUMENT CO LT

13.12 CNY

1.19B USD 1Y -19.8%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

5 Metrics

Country

Region

Sector

Industry

Medical Devices

Website

https://www.szyhlo.com

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

46.0% p.a.

Max Drawdown (5Y)

-77.0%

Sharpe Ratio (5Y)

-0.34

Beta Factor

0.20

Size Class

Mid Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 High valuation risk: Avg P/E of 95.1 (Elevated multiple compression risk)

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (46.0% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -77.0% in the extended horizon.